Results for Beta Thalassemia

In the Emerging Innovators in Collaborative Research Program, up-and-coming researchers highlight their work.

This week in the news, we share findings on Fontan circulation side effects, pediatric brain tumor survivorship, gene therapy, and more.

Stefano Rivella, PhD, is developing a new gene therapy — a multitasking vector — for treatment of red blood disorders.

The 17th Research Institute Scientific Symposium, held virtually on May 20, highlighted advances in cell and gene therapy.

The 2021 Distinguished Research Trainee Award recipients include trainees from a variety of levels and disciplines.

CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.

This week’s In the News features firearms research, stillbirths during COVID, donations to the Friedreich’s Ataxia Center of Excellence, and postdocs highlighted for diversity.

Stefano Rivella, PhD Studies Problem of Too Much Iron Absorption, Leading Cause of Death in Beta-Thalassemia

Come with us "Off Campus," and discover what our employees do for fun, recreation, and their communities. First up: Stefano Rivella, PhD.